Empowering Pediatricians With Direct Penicillin Challenges: A Promising Delabeling Strategy

Katherine Park1, David J Schwartz1

  • 1Department of Allergy and Immunology, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.

Military Medicine
|September 28, 2024
PubMed

Insights

Penicillin allergy delabeling is safe and effective in low-risk pediatric patients. A 100% success rate was observed in direct oral penicillin challenges, supporting broader implementation in primary care.

Area of Science:

  • Allergy and Immunology
  • Clinical Pediatrics
  • Pharmacology

Background:

  • Penicillin allergy labels are often inaccurate and can lead to unnecessary avoidance of first-line antibiotics.
  • A multidisciplinary approach is recommended for penicillin allergy delabeling.
  • Direct oral challenges are a key component of delabeling low-risk patients.

Purpose of the Study:

  • To evaluate the success rate of penicillin challenges at a military medical center.
  • To assess the safety and reaction rate of direct oral penicillin challenges in low-risk pediatric patients.

Main Methods:

  • Retrospective review of 74 pediatric penicillin challenges from June 2019 to May 2023.
  • Patients were screened for reaction history; low-risk individuals underwent direct graded oral challenges without prior skin testing.
  • Higher-risk patients or those with recent reactions/multiple allergies proceeded to skin testing with penicillin agents.

Main Results:

  • All 74 pediatric patients successfully passed their penicillin challenges.
  • A 100% pass rate was achieved for both direct oral challenges and challenges following skin testing.

Conclusions:

  • Direct oral penicillin challenges demonstrate a high success and safety rate in low-risk pediatric populations.
  • Expansion of penicillin delabeling strategies into primary care settings should be considered.
  • Allergists should lead efforts to educate peers and promote multidisciplinary penicillin allergy delabeling.
Abstract